CMS Input On Pivotal Trials Could Anticipate Medicare Coverage Issues – Brooks-LaSure

 
• By Cathy Kelly

Centers for Medicare and Medicaid Services Administrator Chiquita Brooks-LaSure responds to US Congressional concerns about the proposed Medicare coverage policy for Alzheimer’s drugs.

CMS tries to educate Congress on Medicare coverage policy as its final Alzheimer's drug decision approaches. • Source: Alamy

More from Medicare

More from Government Payers